| DIRECT COMPETITOR COMPARISON | |
| BDSI | CEPH | EMIS.OB | ENDP | Industry | | Market Cap: | 83.65M | 4.12B | 31.55M | 2.62B | 100.26M | | Employees: | 20 | 2,780 | 20 | 1,216 | 68 | | Qtrly Rev Growth (yoy): | -88.30% | 10.20% | N/A | 14.00% | 19.70% | | Revenue (ttm): | 107.54K | 2.16B | 5.00K | 1.42B | 14.01M | | Gross Margin (ttm): | N/A | 82.61% | 100.00% | 75.15% | 65.67% | | EBITDA (ttm): | -17.57M | 703.00M | -15.43M | 461.38M | -12.30M | | Oper Margins (ttm): | -17,031.60% | 24.96% | -322,640.00% | 27.58% | -149.46% | | Net Income (ttm): | -29.89M | 280.69M | -21.34M | 197.58M | N/A | | EPS (ttm): | -1.513 | 3.618 | -0.673 | 1.685 | -0.33 | | P/E (ttm): | N/A | 15.27 | N/A | 13.26 | 16.37 | | PEG (5 yr expected): | N/A | 0.85 | N/A | 0.86 | 1.31 | | P/S (ttm): | 781.72 | 1.91 | 5721.52 | 1.87 | 9.35 |
|
| CEPH = Cephalon Inc. | | EMIS.OB = Emisphere Technologies, Inc. | | ENDP = Endo Pharmaceuticals Holdings Inc. | | Industry = Biotechnology | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.59 | 0.16% | 57.28B | 12.34 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.47 | 1.17% | 13.73B | 15.89 | | Genzyme Corp. | GENZ | 51.60 | 1.04% | 13.69B | 29.42 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.3428 | -0.47% | 41.71B | 17.92 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.824 | -0.25% | 8.89B | 1016.82 | | Teva Pharmaceutical Industries Limited | TEVA | 53.09 | 0.40% | 46.77B | 48.57 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.71 | 2.03% | 4.00B | 19.44 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.97 | 0.17% | 2.97B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.98 | -0.17% | 5.49B | 110.31 | | Pfizer Inc. | PFE | 18.42 | 0.93% | 148.64B | 15.30 | | Johnson & Johnson | JNJ | 62.735 | -0.25% | 173.09B | 13.70 | | GlaxoSmithKline plc | GSK | 41.66 | -1.42% | 105.61B | 13.23 | | Sanofi-Aventis | SNY | 38.32 | -0.29% | 100.06B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.80 | 0.76% | 126.73B | 16.71 | | RHHBY.PK | 41.04 | -1.01% | N/A | N/A | | AstraZeneca plc | AZN | 44.85 | -0.97% | 65.03B | 9.01 | | Abbott Laboratories | ABT | 54.01 | -0.13% | 83.54B | 14.63 | | Bristol-Myers Squibb Co. | BMY | 25.57 | 0.75% | 50.65B | 13.23 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | EMIS.OB | | Emisphere Technologies Announces Extension of Maturity Date for Novartis Convertible Promissory Note
Mon 8:45am -
Business Wire | | • | CEPH | | [$$] Sorting Through the Stock Laggards of 2009
Fri, Nov 27 -
at Barrons.com | | • | ENDP | | Prospecting for Stocks: Novartis
Wed, Nov 25 -
at Motley Fool | | • | ENDP | | 12 Companies With Ironclad Balance Sheets
Wed, Nov 25 -
at Motley Fool | | • | CEPH | | Cephalon Settles Barr Challenge
Wed, Nov 25 -
Zacks.com | | • | CEPH | | [$$] Stocks in the Spotlight Monday
Tue, Nov 24 -
at Barrons.com | | • | CEPH | | H-P: Analysts' Upgrades, Downgrades
Tue, Nov 24 -
at TheStreet.com | | • | EMIS.OB | | Emisphere Technologies to Present at the New York Society of Security Analysts' 13th Annual Biotech & Specialty Pharma Investment Conference
Tue, Nov 24 -
Business Wire | | • | CEPH | | Cephalon upgraded by Jefferies & Co
Tue, Nov 24 -
Briefing.com | | • | CEPH | | [$$] Verizon Advances 3%; Chevron, Exxon Rise
Tue, Nov 24 -
at The Wall Street Journal Online | | • | ENDP | | Which Drug Companies Could Be Private-Equity Targets?
Mon, Nov 23 -
at The Wall Street Journal Online | | • | EMIS.OB | | NYSSA Presents 13th Annual Biotech and Specialty Pharmaceuticals Conference
Fri, Nov 20 -
Business Wire | | • | EMIS.OB | | EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers
Mon, Nov 16 -
EDGAR Online | | • | ENDP | | ENDO PHARMACEUTICALS HOLDINGS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Fri, Nov 13 -
EDGAR Online | | • | EMIS.OB | | EMISPHERE TECHNOLOGIES INC Financials
Fri, Nov 13 -
EDGAR Online Financials | | • | ENDP | | Endo paying $23M to settle patent dispute with LecTec
Thu, Nov 12 -
at bizjournals.com | | • | ENDP | | UPDATE - Endo and LecTec settle patent dispute
Wed, Nov 11 -
at Reuters | | | All Headlines for these symbols... |
|
|
|
0.31% Nasdaq 
0.02%
Competitors
